RAFAEL
RUBIO GARCÍA
Profesor titular de universidad
![Foto de RAFAEL](/img/uploaded/6CA654DD031F6FEF08160B3A8AA5CC20.jpg)
![Foto de Hospital de Móstoles](/img/noimage_org.png)
Hospital de Móstoles
Móstoles, EspañaPublicacions en col·laboració amb investigadors/es de Hospital de Móstoles (15)
2020
-
Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)
Scientific Reports, Vol. 10, Núm. 1
2017
2015
-
Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus
Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958
2014
-
Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis
Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287
2013
-
Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus
Journal of Hepatology, Vol. 58, Núm. 6, pp. 1104-1112
2012
-
Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with hiv and hepatitis c virus
Clinical Infectious Diseases, Vol. 55, Núm. 5, pp. 728-736
2011
-
Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus
Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 12, pp. 2843-2849
2008
-
Efectos secundarios graves derivados de las interacciones medicamentosas del tratamiento antirretroviral
Revista Clinica Espanola, Vol. 208, Núm. 11, pp. 557-560
-
New CCR5 inhibitor antiretroviral drugs and integrase inhibitors
Revista Clinica Espanola, Vol. 208, Núm. 9, pp. 463-466
2005
-
Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: Frequency, characterization and risk factors
Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 5, pp. 800-804
2004
-
Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjects
Vaccine, Vol. 22, Núm. 23-24, pp. 2966-2973
2002
-
Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999
Sexually Transmitted Infections, Vol. 78, Núm. 4, pp. 255-260
-
Tratamiento antirretroviral inicial
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 20, Núm. SUPPL.2, pp. 3-9
1996
-
ESTUDIO TRANSVERSAL MULTIHOSPITALARIO DE TUBERCULOSIS Y RESISTENCIAS EN MADRID (OCTUBRE DE 1993-ABRIL DE 1994)
Medicina Clinica, Vol. 106, Núm. 1, pp. 1-6
1989
-
Visceral leishmaniasis (Kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in spain
Reviews of Infectious Diseases, Vol. 11, Núm. 4, pp. 655-660